Nazım S. Turhal
Kosekoy, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Chronic kidney disease and denosumab in metastatic bone disease: A multicenter Turkish cohort study on severe hypocalcemia, skeletal events, and survival.
Journal: Journal of bone oncology
Published: October 18, 2025
Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?
Journal: Current oncology (Toronto, Ont.)
Published: August 04, 2024
Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.
Journal: BMC cancer
Published: January 23, 2024
Evaluating the performance of the MSKCC gastric cancer survival calculator in the Turkish population.
Journal: Turkish journal of medical sciences
Published: January 06, 2024
Adrenocortical Cancer in the Real World: A Comprehensive Analysis of Clinical Features and Management from the Turkish Oncology Group (TOG).
Journal: Clinical genitourinary cancer
Published: August 27, 2023
The real-world outcomes of Lutetium-177 PSMA-617 radioligand therapy in metastatic castration-resistant prostate cancer: Turkish Oncology Group multicenter study.
Journal: International journal of cancer
Published: August 16, 2023
Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.
Journal: BMC cancer
Published: February 21, 2023
Major and minor salivary gland cancers: A multicenter retrospective study.
Journal: Head & neck
Published: November 24, 2022
Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group.
Journal: Journal of cancer research and clinical oncology
Published: March 11, 2022
Metastatic colorectal cancer in both sides of Aegean sea: practice patterns and outcome.
Journal: Current medical research and opinion
Published: February 03, 2022
Efficacy and tolerability of current treatments for hormone-refractory prostate cancer patients with visceral metastases.
Journal: Future oncology (London, England)
Published: February 26, 2021
Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group.
Journal: Journal of gastrointestinal cancer
Published: January 24, 2021
Last Updated: 09/26/2026